Low-grade gliomas: clinical and pathobiological aspects

Area of Science:

• Neuro-oncology
• Molecular Biology
• Genetics

Background:

• Low-grade gliomas present diverse natural histories and treatment controversies.
• Optimal management strategies require continuous re-evaluation based on evolving research.
• Advances in neuro-oncology offer new perspectives on understanding and treating these tumors.

Purpose of the Study:

• To review recent advancements in the clinical and biological understanding of low-grade gliomas.
• To highlight the translation of basic research findings into clinical practice for low-grade gliomas.
• To discuss emerging approaches for improved classification and treatment of low-grade gliomas.

Main Methods:

• Review of current literature on low-grade glioma research.
• Analysis of molecular genetic profiling in oligodendroglioma management.
• Examination of experimental studies on molecular pathways and treatment resistance.

Main Results:

• Molecular genetic profiling is beginning to guide treatment for some oligodendroglioma patients.
• Understanding of molecular pathways has elucidated mechanisms of glioma resistance to radiotherapy and chemotherapy.
• Future classification improvements may arise from characterizing genetic heterogeneity and identifying tumor stem cells.

Conclusions:

• New research in neuro-oncology is providing critical insights into low-grade gliomas.
• Translational research is essential for improving clinical management and treatment efficacy.
• Advancements in molecular characterization promise more precise classification and personalized treatment strategies for low-grade gliomas.